DRUG
🇦🇺 ASX
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💰
0.33%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
51
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.
📈 Performance
Price History
+54.42%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
KRW - KOREAN WON
NOVO NORDISK A/S
4.39%
NOVARTIS AG
3.88%
ROCHE HOLDING AG
3.83%
ASTRAZENECA PLC
3.72%
Updated as of 25 May 2023
Industry Exposure
📞 Communication
34%
📙 Other
33%
🩺 Health
33%
Country Exposure
Other
67%
🇺🇸 United States of America (the)
23%
🇨🇭 Switzerland
3%
🇬🇧 United Kingdom of Great Britain and Northern Ireland (the)
2%
🇩🇰 Denmark
2%
🇯🇵 Japan
1%
🇫🇷 France
1%
🇮🇪 Ireland
1%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
0.33%
💰 Annual Distribution Earnings Per $1,000 invested**
$3.35
💰 Most Recent Distribution Franked Percentage Estimate
0.00%
💰 Average Distribution Franked Percentage Estimate
0.00 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.02
NaN%
2021
$0.37
0.00%
2020
$0.07
0.00%
2019
$0.02
NaN%
2018
$0.20
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
💵 Costs
💼
0.57%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$7.69
💰 Price To Earnings Ratio
19.34
💰 Price To Book Ratio
4.60
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in DRUG
51
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in DRUG
694 days
DRUG investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
21%
50k - 100k
46%
Less than 50k
23%
👶 Age of investors
18 - 25
8%
26 - 34
53%
35 - 90
39%
🙋 Legal gender of investors
Female
63%
Male
37%
Pearlers who invest in DRUG also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
📊 Share price
$12.45 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
📊 Share price
$100.01 AUD
NULL GLOBAL
NULL OTHER
NULL SMART BETA
NULL THEMATIC
NULL INDEX
Want more shares? Try these...
Diatreme Resources Ltd. engages in the exploration of mineral sands, copper, gold and base metals in Australia. The company is headquartered in Brisbane, Queensland and currently employs 90 full-time employees. The company went IPO on 2005-06-22. Its projects include the Galalar Silica Project, the Cyclone Zircon Project, and Clermont Copper/Gold Project. Its flagship project, Galalar Silica Project, is located approximately 200 kilometers north of Cairns and the silica sand mine at Cape Flattery in Far North Queensland. Galalar Silica Project is engaged in producing silica for the solar panel market. Cyclone Zircon Project is situated in Western Australia on the Barton shoreline along the northern margin of the Eucla Basin, approximately 25 km from Western Australia’s state border with South Australia and 220 kilometers north of the transcontinental railway. Clermont Copper/Gold Project is located around the town of Clermont in central Queensland for exploring porphyry copper/gold and mesothermal gold. The company is focused on expanding silica sand projects in Far North Queensland to produce a product for the solar power revolution.
📊 Share price
$0.03 AUD
Deterra Royalties Ltd. operates as a royalty company. The company is headquartered in Perth, Western Australia and currently employs 8 full-time employees. The company went IPO on 2020-10-23. The Company’s portfolio includes royalties held over Mining Area C, its cornerstone asset, in the Pilbara region of Western Australia, as well as five smaller royalties, including Yoongarillup/Yalyalup, Wonnerup, Eneabba and St Ives. Its key royalty investment activities involve acquisition of royalties from third parties and providing finance to resource companies in return for royalties. The Company’s projects include Mining Area C (MAC), Yoongarillup / Yalyalup Mineral Sands Mines, Wonnerup Mineral Sands, St Ives Gold Project and Eneabba Project. MAC is located approximately 90 kilometers (km) northwest of Newman Township in the Pilbara region of Western Australia, which is an iron ore province. MAC produces approximately 145 million tons of iron ore per annum.
📊 Share price